Patients Coming Off Slimming Jabs Gain Back Pounds at a Quadrupled Rate Compared to Those on Conventional Diets

A recent study reveals that patients who discontinue blockbuster slimming jabs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who halt conventional lifestyle plans.

Research printed in a leading health publication demonstrates that while obese individuals often shed about a fifth of their body weight while using the jabs, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.

"Individuals buying these drugs need to be aware of the risk of rapid rebound weight gain when the medication concludes," stated researcher Dr. Susan Jebb.

Such speed of recovery suggests a return to original mass in about one and a half years.

Analyzing Therapies

The research, which examined dozens of studies involving thousands of patients, contrasted the effects of the injectable medications with other pills.

Researchers note that individuals who shed pounds through dieting generally experience a more gradual weight regain—approximately 100 grams monthly—post-intervention.

Understanding the Rapid Rebound

Experts suggest the mechanism of the jabs is key to understanding the accelerated regain.

These medications imitate a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Artificially providing GLP-1 levels several times higher than normal might result in the body to produce less of its endogenous hormone, and may also reduce responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.

"Stopping of this medication means appetite is no longer kept in check, making excessive eating a significant risk."

An Ongoing Disease?

Health authorities recommend the injections for people with obesity-related medical conditions, alongside recommended diet and exercise modifications.

A number of clinicians say that, considering the likelihood of weight regain, the treatment should be considered long-term.

This opinion is reinforced by drug manufacturers, who say that the findings "emphasize the chronic character of obesity," similar to managing diseases like hypertension.

Patient Accounts

Users who have discontinued the jabs describe a powerful resurgence of appetite.

"I experienced a trigger activating and you become ravenous," said a patient.

This difficulty is worsened if users have not established permanent dietary or behavioural changes during therapy.

Widespread Use

Figures indicate that a significant number of people in the UK have tried these injections in the past year, with interest continuing to grow.

• Use is more common among females than men.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion access the drugs through private healthcare rather than the NHS.

Finally, researchers stress that while the jabs are powerful agents for weight loss, they are not a magic cure and lasting health benefits hinges on integrated lifestyle changes.